MAPT and Alzheimer disease: Numbers of biochemical processes are affected in AD pathologies, which include the breakdown of amyloid precursor proteins, the phosphorylation of tau proteins, oxidative stress, poor energy, mitochondrial dysfunction, inflammation, membrane lipid dysregulation, or disruption of neurotransmitter pathways (de la Monte and Tong, 2014; Procaccini et al., 2016).